Manchester United manager Erik ten Hag was frustrated with his side’s lack of clinical finishing in their goalless draw with ...

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, ...

Whilst J&J’s Shockwave has a strong grasp on the IVL market, other players are emerging with differentiated technologies.

When surveyed, many physicians said the belief that patients had adequate symptom control was why they didn’t add more meds.

KENNETT SQUARE, PA — Powerback Rehabilitation has announced a strategic partnership with PredictionHealth to incorporate ...

Health tech startup Dandelion Health launched a clinical artificial intelligence marketplace that merges third-party ...

Patients can benefit from clinical trials in gynecologic cancers, and knowing that they can advocate for themselves for ...

London, UK and New York, USA, September 10, 2024 - Abingworth, a leading transatlantic life sciences investment firm and part ...

Valerie M. Harvey, MD, MPH, FAAD, founder of the Hampton Roads Center for Dermatology, highlighted the long-standing ...

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vasc ...

Enfortumab vedotin showed a robust disease control rate in patients with urothelial cancer outside of a clinical trial, and ...

Canaccord Genuity analyst John Newman has maintained their bullish stance on ONCY stock, giving a Buy rating yesterday. John Newman has given ...